UY29245A1 - MEDICAL COMBINATIONS - Google Patents
MEDICAL COMBINATIONSInfo
- Publication number
- UY29245A1 UY29245A1 UY29245A UY29245A UY29245A1 UY 29245 A1 UY29245 A1 UY 29245A1 UY 29245 A UY29245 A UY 29245A UY 29245 A UY29245 A UY 29245A UY 29245 A1 UY29245 A1 UY 29245A1
- Authority
- UY
- Uruguay
- Prior art keywords
- combinations
- medical combinations
- medical
- azoniabicyclo
- octanes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a los derivados olefínicos de 8-azoniabiciclo (3.2.1) octanos, a composiciones farmacéuticas de los mismos y a su uso en el tratamiento de enfermedades mediadas por el receptor muscarínico de acetilcolina del tracto respiratorio, combinaciones de los mismos y métodos para utilizarlos.The invention relates to the olefinic derivatives of 8-azoniabicyclo (3.2.1) octanes, pharmaceutical compositions thereof and their use in the treatment of diseases mediated by the muscarinic acetylcholine receptor of the respiratory tract, combinations thereof and methods. to use them
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63361804P | 2004-12-06 | 2004-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29245A1 true UY29245A1 (en) | 2006-05-31 |
Family
ID=36578468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29245A UY29245A1 (en) | 2004-12-06 | 2005-12-02 | MEDICAL COMBINATIONS |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR052145A1 (en) |
PE (1) | PE20060826A1 (en) |
TW (1) | TW200633715A (en) |
UY (1) | UY29245A1 (en) |
WO (1) | WO2006062931A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20050250A1 (en) | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLIN MUSCARINAL RECEPTORS |
CN1893948A (en) | 2003-10-14 | 2007-01-10 | 葛兰素集团有限公司 | Muscarinic acetylcholine receptor antagonists |
BRPI0415281A (en) | 2003-10-17 | 2006-12-19 | Glaxo Group Ltd | muscarinic acetylcholine receptor antagonists |
PE20050489A1 (en) | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS |
US7384946B2 (en) | 2004-03-17 | 2008-06-10 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
PE20060259A1 (en) | 2004-04-27 | 2006-03-25 | Glaxo Group Ltd | QUINUCLIDINE COMPOUNDS AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR |
EP1747219A4 (en) | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists field of the invention |
JP2008520579A (en) | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | Novel M3 muscarinic acetylcholine receptor antagonist |
WO2007022351A2 (en) | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP2080523A1 (en) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Compositions comprising an antimuscarinic and a long-acting beta-agonist |
AR070562A1 (en) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | DUAL PHARMACOPHORS - PDE4 MUSCARINIC ANTAGONISTS |
TW200946526A (en) | 2008-02-06 | 2009-11-16 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
AR070563A1 (en) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | COMPOSITE OF A CONDENSED BICYCLE PIRAZOL-PIRIDIN-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF RESPIRATORY DISEASES. |
EP4403231A2 (en) | 2009-02-26 | 2024-07-24 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
JP2014516062A (en) * | 2011-06-08 | 2014-07-07 | グラクソ グループ リミテッド | Combinations containing umecridinium and corticosteroids |
RU2666963C2 (en) | 2012-04-13 | 2018-09-13 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Aggregated particles |
GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1140998B (en) * | 1980-06-18 | 1986-10-10 | Valeas Ind Chimica E Farmaceut | ENDO-8-METHYL-8-SIN-ALCHIL-8-AZONIABICYCLE OPEN SALTS PAR. SQUARE 3.2.1. CLOSED PAR. QUADRATA-OTTAN-3-ALCHILCARBOSSILATI, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT |
IT1194343B (en) * | 1983-07-26 | 1988-09-14 | Valeas Spa | ENDO-8,8-DIALKYL-8-AZONIABICICLO SALTS (3.2.1) OTTAN-6,7-ESSO-EPOSSI-3-ALCHILCARBOSSILATI, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT |
DE19528145A1 (en) * | 1995-08-01 | 1997-02-06 | Boehringer Ingelheim Kg | New drugs and their use |
US20030013675A1 (en) * | 2001-05-25 | 2003-01-16 | Boehringer Ingelheim Pharma Kg | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |
-
2005
- 2005-12-01 PE PE2005001396A patent/PE20060826A1/en not_active Application Discontinuation
- 2005-12-02 UY UY29245A patent/UY29245A1/en unknown
- 2005-12-05 WO PCT/US2005/044033 patent/WO2006062931A2/en active Application Filing
- 2005-12-05 TW TW094142714A patent/TW200633715A/en unknown
- 2005-12-05 AR ARP050105079A patent/AR052145A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006062931A2 (en) | 2006-06-15 |
TW200633715A (en) | 2006-10-01 |
AR052145A1 (en) | 2007-03-07 |
PE20060826A1 (en) | 2006-10-08 |
WO2006062931A3 (en) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29245A1 (en) | MEDICAL COMBINATIONS | |
UY29244A1 (en) | MEDICAL COMBINATIONS | |
CO6270364A2 (en) | PIRIDINE AND PIRAZINE DERIVATIVES USED IN THE TREATMENT OF CELL PROLIFERATION DISORDERS | |
ECSP088329A (en) | NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8 | |
UY28766A1 (en) | ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER | |
CL2007002708A1 (en) | COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS. | |
CL2008003096A1 (en) | Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others. | |
AR057239A1 (en) | IMMUNOGLOBULINS | |
PA8586001A1 (en) | INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES | |
DOP2006000084A (en) | SULFOXIMINO-MACROCICLIC COMPOUNDS AND THEIR SALTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PREPARATION METHODS AND USES OF THE SAME | |
CL2008002139A1 (en) | Dimer compounds derived from pyrrolo [2,1c] [1,4] benzodiazepine-5 -one (tomaimycin), a conjugate comprising them; procedure of preparation of conjugates; pharmaceutical composition comprising the compounds or conjugates; and use of compounds and conjugates in the treatment of cancer. | |
SV2010003451A (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
ECSP077349A (en) | NEW DERIVATIVES OF SULFONAMIDE AS GLUCOCORTICOID RECEPTOR MODULATORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
ECSP066391A (en) | [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA | |
WO2006053049A3 (en) | Herbal composition phy906 and its use in chemotherapy | |
ECSP067114A (en) | N-SUBSTITUTED PIPERIDINS AND THEIR USE AS PHARMACEUTICALS | |
UY28922A1 (en) | RECEIVER CB1 LINKS USEFUL IN THE TREATMENT OF PAIN AND / OR OTHER SYMPTOMS OR RELATED DISEASES; PHARMACEUTICAL COMPOUNDS AND THEIR PREPARATION. | |
UY31314A1 (en) | HETEROCICLIC AMIDAS AND ITS METHODS OF USE-976 | |
ECSP066978A (en) | AMINO COMPOUNDS AND ITS USE AS PHARMACEUTICALS | |
CL2007001918A1 (en) | SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS. | |
IL184051A (en) | Acylated glp-1 compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
UY29087A1 (en) | ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE | |
GT200500325A (en) | PIRAZOLO-PIRIMIDINAS 1,4-REPLACED AS QUINASA INHIBITORS | |
CL2008002852A1 (en) | Compounds derived from 7-fluoro-5-methyl-2- (phenylamino) -6,7,8,9-tetrahydro-5h-pyrimido [4,5-b] [1,4] diazepin-6 (7h) -one ; pharmaceutical composition comprising said compounds; and its use in the treatment of cancers, inflammation, alopecia, autoimmune, cardiovascular, infectious, nephrological, neurodfegenerative, skin and bone diseases. |